NO131698B - - Google Patents

Download PDF

Info

Publication number: NO131698B
Authority: NO; Norway
Prior art keywords: pyridyl; new; compound; ethyl; ethylhydrazine
Prior art date: 1969-07-16

Application number

NO2725/70A

Other languages

English (en)

Norwegian (no)

Other versions

NO131698C (fr

Inventor

H Carbonnet

Frere J Le

Original Assignee

Alsacienne Atom

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1969-07-16

Filing date

1970-07-10

Publication date

1975-04-01

1970-07-10 Application filed by Alsacienne Atom filed Critical Alsacienne Atom

1975-04-01 Publication of NO131698B publication Critical patent/NO131698B/no

1975-07-09 Publication of NO131698C publication Critical patent/NO131698C/no

Links

JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 claims description 10
229940079593 drug Drugs 0.000 claims description 10
239000003814 drug Substances 0.000 claims description 10
HMCWZAZLRFMRPY-UHFFFAOYSA-N 2-pyridin-4-ylethylhydrazine Chemical compound NNCCC1=CC=NC=C1 HMCWZAZLRFMRPY-UHFFFAOYSA-N 0.000 claims description 6
210000003169 central nervous system Anatomy 0.000 claims description 6
229940040102 levulinic acid Drugs 0.000 claims description 5
NSLJAVZPTLLIER-UHFFFAOYSA-N 6-methyl-2-(2-pyridin-4-ylethyl)-4,5-dihydropyridazin-3-one Chemical compound O=C1CCC(C)=NN1CCC1=CC=NC=C1 NSLJAVZPTLLIER-UHFFFAOYSA-N 0.000 claims description 4
238000000034 method Methods 0.000 claims description 3
125000005907 alkyl ester group Chemical group 0.000 claims description 2
238000002360 preparation method Methods 0.000 claims description 2
150000001875 compounds Chemical class 0.000 description 15
230000003213 activating effect Effects 0.000 description 9
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
241000699670 Mus sp. Species 0.000 description 4
AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical compound OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 3
-1 alkyl levulinate Chemical compound 0.000 description 3
239000007795 chemical reaction product Substances 0.000 description 3
230000000694 effects Effects 0.000 description 3
UYXAWHWODHRRMR-UHFFFAOYSA-N hexobarbital Chemical compound O=C1N(C)C(=O)NC(=O)C1(C)C1=CCCCC1 UYXAWHWODHRRMR-UHFFFAOYSA-N 0.000 description 3
229960002456 hexobarbital Drugs 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
230000004913 activation Effects 0.000 description 2
239000003610 charcoal Substances 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000001816 cooling Methods 0.000 description 2
229940064790 dilantin Drugs 0.000 description 2
238000004821 distillation Methods 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
238000003756 stirring Methods 0.000 description 2
QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
206010002091 Anaesthesia Diseases 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
GMEONFUTDYJSNV-UHFFFAOYSA-N Ethyl levulinate Chemical compound CCOC(=O)CCC(C)=O GMEONFUTDYJSNV-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
206010067482 No adverse event Diseases 0.000 description 1
QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
241001279009 Strychnos toxifera Species 0.000 description 1
208000010513 Stupor Diseases 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
230000001773 anti-convulsant effect Effects 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
229960003965 antiepileptics Drugs 0.000 description 1
230000037396 body weight Effects 0.000 description 1
238000009835 boiling Methods 0.000 description 1
239000002775 capsule Substances 0.000 description 1
RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
229960002327 chloral hydrate Drugs 0.000 description 1
ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
229960001076 chlorpromazine Drugs 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
239000012043 crude product Substances 0.000 description 1
125000004494 ethyl ester group Chemical group 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229940058352 levulinate Drugs 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000000203 mixture Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
229960001412 pentobarbital Drugs 0.000 description 1
239000008024 pharmaceutical diluent Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
239000012264 purified product Substances 0.000 description 1
NWELCUKYUCBVKK-UHFFFAOYSA-N pyridin-2-ylhydrazine Chemical compound NNC1=CC=CC=N1 NWELCUKYUCBVKK-UHFFFAOYSA-N 0.000 description 1
125000004076 pyridyl group Chemical group 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
238000010992 reflux Methods 0.000 description 1
229960005453 strychnine Drugs 0.000 description 1
150000005846 sugar alcohols Polymers 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000003826 tablet Substances 0.000 description 1

Classifications

- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02K—DYNAMO-ELECTRIC MACHINES
- H02K44/00—Machines in which the dynamo-electric interaction between a plasma or flow of conductive liquid or of fluid-borne conductive or magnetic particles and a coil system or magnetic field converts energy of mass flow into electrical energy or vice versa
- H02K44/02—Electrodynamic pumps
- H02K44/06—Induction pumps

Landscapes

Engineering & Computer Science (AREA)
Power Engineering (AREA)
Structures Of Non-Positive Displacement Pumps (AREA)
General Induction Heating (AREA)
Electromagnetic Pumps, Or The Like (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Filling Or Discharging Of Gas Storage Vessels (AREA)
Press Drives And Press Lines (AREA)
Extraction Or Liquid Replacement (AREA)

NO2725/70A 1969-07-16 1970-07-10 NO131698C (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR6924241A FR2052105A6 (fr)	1969-07-16	1969-07-16

Publications (2)

Publication Number	Publication Date
NO131698B true NO131698B (fr)	1975-04-01
NO131698C NO131698C (fr)	1975-07-09

Family

ID=9037545

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO2725/70A NO131698C (fr)	1969-07-16	1970-07-10

Country Status (8)

Country	Link
US (1)	US3656867A (fr)
JP (1)	JPS5434164B1 (fr)
CA (1)	CA946903A (fr)
CH (1)	CH528176A (fr)
DE (1)	DE7026816U (fr)
FR (1)	FR2052105A6 (fr)
GB (1)	GB1313374A (fr)
NO (1)	NO131698C (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH604422A5 (fr) *	1973-02-09	1978-09-15	Alsacienne Atom
JPS49133802U (fr) *	1973-03-14	1974-11-18
JPS5121211A (ja) *	1974-08-15	1976-02-20	Doryokuro Kakunenryo	Denjihonpu
JPS5219307A (en) *	1975-08-06	1977-02-14	Toshiba Corp	Ring shaped straight line induction type electro magetic pump
US4255877A (en) *	1978-09-25	1981-03-17	Brs, Inc.	Athletic shoe having external heel counter
JP2014096895A (ja) *	2012-11-08	2014-05-22	Toshiba Corp	電磁ポンプ
US11049624B2 (en)	2015-12-07	2021-06-29	Ge-Hitachi Nuclear Energy Americas Llc	Nuclear reactor liquid metal coolant backflow control

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2764095A (en) *	1954-02-05	1956-09-25	Mine Safety Appliances Co	Polyphase electromagnetic induction pump
US3005116A (en) *	1957-06-04	1961-10-17	English Electric Co Ltd	Discontinuous induction type dynamoelectric machines

1969
- 1969-07-16 FR FR6924241A patent/FR2052105A6/fr not_active Expired
1970
- 1970-07-10 NO NO2725/70A patent/NO131698C/no unknown
- 1970-07-14 CH CH1062770A patent/CH528176A/fr not_active IP Right Cessation
- 1970-07-15 US US54946A patent/US3656867A/en not_active Expired - Lifetime
- 1970-07-15 CA CA088,331*7A patent/CA946903A/en not_active Expired
- 1970-07-16 DE DE7026816U patent/DE7026816U/de not_active Expired
- 1970-07-16 GB GB3463470A patent/GB1313374A/en not_active Expired
- 1970-07-16 JP JP6179970A patent/JPS5434164B1/ja active Pending

Also Published As

Publication number	Publication date
GB1313374A (en)	1973-04-11
FR2052105A6 (fr)	1971-04-09
DE2035329A1 (de)	1971-02-18
CA946903A (en)	1974-05-07
DE7026816U (de)	1977-11-17
JPS5434164B1 (fr)	1979-10-25
DE2035329B2 (de)	1976-05-13
CH528176A (fr)	1972-09-15
NO131698C (fr)	1975-07-09
US3656867A (en)	1972-04-18

Publication	Publication Date	Title
US4052509A (en)	1977-10-04	Method for reducing serum uric acid levels
JPH075588B2 (ja)	1995-01-25	新規ピコリン誘導体及びこれを含有する医薬
JPH0224821B2 (fr)	1990-05-30
JPH0153671B2 (fr)	1989-11-15
JPH0136819B2 (fr)	1989-08-02
US3957850A (en)	1976-05-18	Phenylacetic acid derivatives
JPS5877868A (ja)	1983-05-11	ピリダジン誘導体、その製造法およびそれを有効成分とする中枢神経系賦活剤
CN101970414A (zh)	2011-02-09	11β-羟基类固醇脱氢酶抑制剂
NO131698B (fr)	1975-04-01
CA1327364C (fr)	1994-03-01	¬(diarylmethoxy)alcoyl\|-1 pyrrolidines et piperidines, procede de preparation et medicaments les contenant
KR100281867B1 (ko)	2001-02-15	3-(비스-치환페닐메틸렌)옥신돌유도체
NO132093B (fr)	1975-06-09
WO1994006769A1 (fr)	1994-03-31	Nouvel ester n-cinnamoyl-2-methyle-5-methoxy-3-indole acetique, production et preparation pharmaceutique contenant ledit ester
KR900005133B1 (ko)	1990-07-20	아릴옥시-n-(아미노알킬)-1-피롤리딘 및 피페리딘 카복스아미드 및 카보티오아미드의 제조방법, 및 이를 함유하는 약제조성물
JPH02221269A (ja)	1990-09-04	抗レトロウィルスフランケトン類
JPS6058981A (ja)	1985-04-05	５−ピリジル−１，３−チアゾ−ル誘導体，その製造法およびそれを含んでなる医薬組成物
SU1053749A3 (ru)	1983-11-07	Способ получени 1,2-бис-(никотинамидо)-пропана или его солей с фармацевтически приемлемой кислотой
JPH0625151B2 (ja)	1994-04-06	２−置換シクロヘプトイミダゾ−ル誘導体、抗潰瘍剤及びその製造方法
CH449652A (fr)	1968-01-15	Procédé de préparation de nouvelles hydroxydiamines
IE53738B1 (en)	1989-02-01	1-phenylindazol-3-one compounds, a method of preparing them, intermediates used in the preparation of said compounds and pharmaceutical compositions containing these compounds
US3012032A (en)	1961-12-05	2-[2-(4-pyridyl)-ethyl]-6-methyl-4, 5-dihydro-3-pyridazinone
US4182775A (en)	1980-01-08	Benzoic acids and process for their preparation
JPS6324514B2 (fr)	1988-05-20
US4259335A (en)	1981-03-31	1-Methyl-4-piperidinol esters of 4-quinolinylamino benzoates and antiinflammatory and analgesic compositions and methods employing them
EP0269383A2 (fr)	1988-06-01	1-Aryloxy-4-[(4-aryl)-1-pipérazinyl]-2-butanols utiles pour traiter des manifestations allergiques